Coronavirus India Live Updates: India’s total Covid-19 case count rose to 1,10,16,434 on Tuesday, with 10,584 new infections reported in one day, while recoveries have exceeded 1.07 million rupees, according to data from the Ministry of Health. Union Health.
With 78 new deaths in one day, the total death toll rose to 1,56,463, the updated data showed at 8 a.m.
The number of people who have recovered from the disease reached 1,07,12,665, which translates into a national recovery rate of 97.24 percent, while the fatality rate is 1.42 percent.
Active coronavirus infections in the country have dropped to 1.47,306, representing 1.34 percent of the total number of cases, according to the data.
The Health Ministry said Monday that 86 percent of the 14,000 new cases of Covid-19 reported in the last 24 hours were from five states that are currently witnessing an increase in daily infections. According to ministry data, Maharashtra recorded the highest number of cases with 6,971, followed by Kerala (4,070), Tamil Nadu (452), Karnataka (413) and Punjab (348).
Maharashtra, Kerala and Punjab are among the five states designated “states of concern” by the Center due to the due increase in the number of reported cases in the last week. The other two on the list are Chhattisgarh and Madhya Pradesh.
According to the data, the number of active cases in the country as of Monday was 1,50,055 cases, which represents 1.36 percent of the total positive cases. The Ministry of Health indicated that seven states or UT have not reported any new cases in the last 24 hours.
On Sunday, the Center had written to five states reporting an increase in cases to implement a multi-pronged strategy to curb the spread of Covid-19. While India’s cumulative positivity rate stood at 5.20 percent on Sunday, the Health Ministry said the country’s national average weekly positivity rate was 1.79 percent.
Hyderabad-based vaccine maker Bharat Biotech expects interim data on the efficacy of Covaxin to be available in the next two weeks, according to the company’s president and managing director, Dr. Krishna Ella. This would be the first time the company could provide clarity on how many symptomatic cases of Covid-19 its indigenous vaccine can prevent.
Covaxin received approval for restricted use in an emergency situation from India’s Comptroller General of Medicines on January 3. However, since Bharat Biotech had not finished recruiting and vaccinating enough participants for the Phase 3 trials, approval was without efficacy data. The government said the approval was “in the public interest” as it believed the vaccine, which consists of killed virus particles, would be more effective against mutant strains.
Bharat Biotech previously published non-peer-reviewed data on Covaxin’s ability to protect against the UK strain. According to Ella, the company can modify Covaxin within 15 days of receiving the strain from South Africa, against which other vaccines like Covishield have not been as effective so far.
.